Aloe Socotrina Pellet
Product Images NDC 15631-0018

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aloe Socotrina (NDC 15631-0018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0018

This is a description of a homeopathic medicine that provides temporary relief for hemorrhoids. The medication is available in pellet form, and it is intended for self-treatment of the condition. The recommended dosage for adults is 4 to 6 pellets taken orally three times daily, while children over the age of two years can take 12 pellets per day. It is advised to seek medical assistance if the symptoms do not improve after four days or worsen. The medication should be kept away from children and stored in a cool dark place.*

FDA Label Image

Mini Labels Pellets Fda15631 0018

This is a medication for the temporary relief of hemorrhoids. Its active ingredient is Aloe socotrina 1X and its inactive ingredient is sucrose. It comes in a pellet form that should be taken orally, four pellets, three times a day by adults, and half the adult dose for children aged two years and older. It is not evaluated by the FDA and is based on homeopathic practices. The label includes the medication's NDC, batch number, manufacturing date, and expiration date. It comes with a mini label used with a blister pack for select pack sizes.*

FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

This is a description of a single lactose-free homeopathic remedy, manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The label provides warnings to discontinue use if symptoms do not improve after 4 days, worsen, or if the user is pregnant, nursing or under medication. The product is distributed by Rehomeo and manufactured by Rihomeo Private Limited in India. The notes related to packing indicate the use of appropriate bottle/container sizes and secondary packing (carto box or a blister pack) depending on the contents of the package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.